Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Mallinckrodt
Argus Health
Harvard Business School
Fuji
Cipla

Generated: June 18, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021623

« Back to Dashboard

NDA 021623 describes SYNERA, which is a drug marketed by Galen Specialty and is included in one NDA. It is available from one supplier. There is one patent protecting this drug. Additional details are available on the SYNERA profile page.

The generic ingredient in SYNERA is lidocaine; tetracaine. There are twenty-nine drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the lidocaine; tetracaine profile page.
Summary for 021623
Tradename:SYNERA
Applicant:Galen Specialty
Ingredient:lidocaine; tetracaine
Patents:1
Pharmacology for NDA: 021623
Physiological EffectLocal Anesthesia
Suppliers and Packaging for NDA: 021623
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SYNERA lidocaine; tetracaine PATCH;TOPICAL 021623 NDA Galen US Incorporated 10885-002 10885-002-01 1 PATCH in 1 POUCH (10885-002-01)
SYNERA lidocaine; tetracaine PATCH;TOPICAL 021623 NDA Galen US Incorporated 10885-002 10885-002-10 10 PATCH in 1 CARTON (10885-002-10)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:PATCH;TOPICALStrength70MG;70MG
Approval Date:Jun 23, 2005TE:RLD:Yes
Patent:➤ Try a Free TrialPatent Expiration:Jul 7, 2020Product Flag?YSubstance Flag?Delist Request?

Expired US Patents for NDA 021623

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Galen Specialty SYNERA lidocaine; tetracaine PATCH;TOPICAL 021623-001 Jun 23, 2005 ➤ Try a Free Trial ➤ Try a Free Trial
Galen Specialty SYNERA lidocaine; tetracaine PATCH;TOPICAL 021623-001 Jun 23, 2005 ➤ Try a Free Trial ➤ Try a Free Trial
Galen Specialty SYNERA lidocaine; tetracaine PATCH;TOPICAL 021623-001 Jun 23, 2005 ➤ Try a Free Trial ➤ Try a Free Trial
Galen Specialty SYNERA lidocaine; tetracaine PATCH;TOPICAL 021623-001 Jun 23, 2005 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Covington
US Department of Justice
Julphar
Fuji
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.